Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D₃

Table 4

Comparison of densitometric markers of calcium-phosphate metabolism in the subgroups of patients with deficiency, insufficiency, and normal level of 25-hydroxycholecalciferol.

Parameter	VitDd; n=56; (68%)	VitDi; n=19; (23%)	VitDn; n=7; (9%)	p
T-Score	-1.11 ± 1.24	-0.53 ± 1.43	-0.71 ± 1.05	0.23
Z-score	-0.74 ±1.23	-0.06 ± 1.20	-0.2 ± 1.42	0.14
BMD [g/cm^2]	0.94 ± 0.13	1.00 ± 0.16	0.98 ± 0.12	0.25
OP [%]	50.9	21.0	14.3	0.03
OS [%]	9.4	15.8	14.3	0.74
Fractures [%]	22.0	41.2	28.6	0.31

VitD3: 25-hydroxycholecalciferol, VitDd: vitamin D₃ deficiency, VitDi: vitamin D₃ insufficiency, VitDn: normal vitamin D₃, BMD: bone mineral density, OP: osteopenia, and OS: osteoporosis